Balaji Amines Limited has submitted to the Exchange, the financial results for the period ended March 31, 2025.

Results View source PDF Explain this filing

BALAMINES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.2%Reaction day

₹1491.70

prior close

₹1400.00

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+0.4%-2.5% vs market

Specialty Chemicals peers, median of 82sector+0.0%-2.2% vs sector

On the reaction day the stock moved 2.5 pts less than Nifty Microcap 250 and 2.2 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+3.1

10m

+3.1

15m

+4.1

30m

+3.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.2+0.4-2.5+0.0-2.2

Next day

-3.1+0.7-3.8-0.6-2.5

-3.1+0.7-3.9+0.4-3.5

-0.2+0.5-0.7-0.1-0.1

-0.7+1.0-1.6+0.7-1.4

-1.4+1.5-2.9+0.8-2.1

+0.9+2.8-1.9+2.1-1.2

15d

-6.5-0.7-5.8-1.3-5.2

+24.4+3.7+20.7+1.6+22.8

+15.6+3.0+12.6-1.1+16.7

-2.5-1.4-1.1-3.1+0.5

UpDownMarket · Nifty Microcap 250Sector · Specialty Chemicals peers, median of 82Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Balaji Amines Limited has submitted its financial results for the quarter and full year ended March 31, 2025, to the stock exchange as required under listing regulations. The actual numbers, including revenue, profit, and margin details, are part of the filed results and have not been provided in this announcement excerpt. Investors would need to review the full results document to assess the company's financial performance.

Likely market impact

This is a routine regulatory filing disclosing period-end financials. The actual impact on the stock or shareholders depends on whether the reported numbers beat or miss market expectations, which is not assessable from this announcement alone.